Clinical Trials in Phoenix

Showing 1301-1320 of 14,291 trials

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

NCT04903314

The primary objective of this study is to assess the pharmacokinetics of cenobamate (YKP3089) in pediatric subjects with partial-onset (focal) seizures following single and multiple-dosing.

Partial Epilepsy

SK Life Science, Inc.26 participantsStarted May 2021

Phoenix, Arizona, United States • Bethesda, Maryland, United States • Columbia, Missouri, United States +10 more locations

RECRUITINGPhase 2< 1 mile

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

NCT06990269

Phase 2 study is designed to assess the efficacy of ADX-038 compared with placebo in participants with GA secondary to AMD. Safety, pharmacokinetics (PK), and pharmacodynamics (PD) will also be assessed.

Geographic Atrophy Secondary to Age-related Macular Degeneration

ADARx Pharmaceuticals, Inc.240 participantsStarted Nov 2025

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Beverly Hills, California, United States +14 more locations

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Find Trials by Condition in Phoenix

Comparing Two Methods to Follow Patients With Pancreatic Cysts

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia

Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

Phase 2 Herniorrhaphy Study for Opioid Elimination

REALITY LHON Registry

A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation

Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array

QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma